Real world clinical experience with Abiraterone Acetate: The Singapore experience

被引:0
作者
Chan, J.
Loh, K. Y.
Fong, Y. C.
Wong, A.
Chong, K. T.
Ng, Q. S.
Toh, C. K.
Chow, M.
Rajasekaran, T.
Kanesvaran, R.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
C-10169
引用
收藏
页码:43 / 43
页数:1
相关论文
共 50 条
  • [1] Real-world experience with abiraterone
    Dahut, William L.
    Madan, Ravi A.
    LANCET ONCOLOGY, 2014, 15 (11) : 1188 - 1190
  • [2] Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience
    Darren M. C. Poon
    Kuen Chan
    S. H. Lee
    T. W. Chan
    Henry Sze
    Eric K. C. Lee
    Daisy Lam
    Michelle F. T. Chan
    BMC Urology, 16
  • [3] Abiraterone acetate in metastatic castration-resistant prostate cancer - the unanticipated real-world clinical experience
    Poon, Darren M. C.
    Chan, Kuen
    Lee, S. H.
    Chan, T. W.
    Sze, Henry
    Lee, Eric K. C.
    Lam, Daisy
    Chan, Michelle F. T.
    BMC UROLOGY, 2016, 16
  • [4] Real-world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer: The Singapore experience
    Chan, Johan
    Yap, Shi Yin
    Fong, Yian Ching
    Lim, Heng Chi
    Toh, Chee Keong
    Ng, Quan Sing
    Rajasekaran, Tanujaa
    Chua, Melvin
    Lee, Lui Shiong
    Wong, Alvin
    Loh, Ker Yun
    Chow, Marcus
    Wong, Siew Wei
    Kanesvaran, Ravindran
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (01) : 75 - 79
  • [5] Safety of abiraterone and enzalutamidein French real-world experience
    Scailteux, Lucie-Marie
    Despas, Fabien
    Kerbrat, Sandrine
    Campillo-Gimenez, Boris
    Mathieu, Romain
    Vincendeau, Sebastien
    Balusson, Frederic
    Balusson, Andre
    Nowak, Emmanuel
    Oger, Emmanuel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 466 - 466
  • [6] Abiraterone acetate treatment in patients with castration-resistant prostate cancer with visceral metastases: a real-world experience
    Facchini, Gaetano
    Cavaliere, Carla
    DAniello, Carmine
    Lovanea, Gelsomina
    Rossetti, Sabrina
    ANTI-CANCER DRUGS, 2019, 30 (02) : 179 - 185
  • [7] Real-world experience with abiraterone (vol 15, pg 1188, 2014)
    Dahut, W. L.
    Madan, R. A.
    LANCET ONCOLOGY, 2014, 15 (12) : E528 - E528
  • [8] REAL WORLD EXPERIENCE OF DENOSUMAB IN CLINICAL PRACTICE
    Moran, Conor
    English, Sarah
    McNally, Colette
    Beringer, Timothy
    Lindsay, John
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : 616 - 616
  • [9] Is It Possible That One Patient May Again Experience a Response to Abiraterone Acetate Withdrawal During an Abiraterone Acetate Rechallenge?
    Maines, Francesca
    Veccia, Antonello
    Caffo, Orazio
    EUROPEAN UROLOGY, 2014, 66 (01) : 179 - 180
  • [10] Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort
    Lim, Jasmine
    Amantakul, Akara
    Shariff, Nisha
    Lojanapiwat, Bannakij
    Alip, Adlinda
    Ong, Teng Aik
    Thevarajah, Shankaran
    Ahmayuddin, Firdaus
    Mathew, Adeline
    Sriplakich, Supon
    Vuthiwong, Jaraspong
    Chong, Flora Li Tze
    Saad, Marniza
    CANCER MEDICINE, 2020, 9 (13): : 4613 - 4621